Who
Sandip I. Patel
Director
Company insider
Files Form 4 as: Director, Akari Therapeutics; CFO and General Counsel, AtlasClear Holdings; Director, Peak Bio; Director, Quantum FinTech Acquisition; Director and 10% owner, Monterey Innovation Acquisition.
In numbers
- Trades disclosed
- 43
- Buys
- 3
- Sells
- 1
- Bought
- $47K
- Sold
- $5,700
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 5 Feb 2021
- Last trade
- 14 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 16 Oct 2026 | AKTX Akari TherapeuticsBiotechnology | SEC FORM 4 Code M | $23,866 at $0.0004 | filing |
| 14 Oct 2026filed 16 Oct 2026 | AKTX Akari TherapeuticsBiotechnology | SEC FORM 4 Code M | $26,186 at $0.0004 | filing |
| 14 Oct 2026filed 16 Oct 2026 | AKTX Akari Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | $62K3,866 at $16.16 | filing |
| 14 Oct 2026filed 16 Oct 2026 | AKTX Akari Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | $100K6,186 at $16.16 | filing |
| 5 Oct 2026filed 16 Oct 2026 | AKTX Akari TherapeuticsBiotechnology | SEC FORM 4 Code A | $34K4,313 at $7.90 | filing |
| 1 Oct 2026filed 2 Oct 2026 | ATCH AtlasClear Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —777,332 at $0.00 | filing |
| 25 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | $9,87550,000 at $0.1975 | filing |
| 25 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | $10K50,000 at $0.20 | filing |
| 25 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $9,87550,000 at $0.1975 | filing |
| 25 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $10K50,000 at $0.20 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | $11K50,000 at $0.2173 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | $11K50,000 at $0.22 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $11K50,000 at $0.2173 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ATCH AtlasClear HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $11K50,000 at $0.22 | filing |
| 18 Aug 2026filed 16 Oct 2026 | AKTX Akari TherapeuticsBiotechnology | SEC FORM 4 Code A | $96K12,100 at $7.90 | filing |
| 18 Aug 2026filed 16 Oct 2026 | AKTX Akari Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 18 Aug 2026filed 16 Oct 2026 | AKTX Akari Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Jul 2026filed 16 Jul 2026 | ATCH AtlasClear Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 14 Jul 2026filed 16 Jul 2026 | ATCH AtlasClear Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —731,030 at $0.00 | filing |
| 14 Jul 2026filed 16 Jul 2026 | ATCH AtlasClear Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
News
AtlasClear To Acquire Ark Financial Services For Up To $24.5 MlnATCH · rttnews.com · 15 Oct 2026AtlasClear Holdings Signs Definitive Agreement to Acquire Ark Financial Services, including its Dawson James Securities Subsidiary, and Completes Initial 24.9% InvestmentATCH · manilatimes.net · 15 Oct 2026
0 headlines in the last 90 days name Sandip I. Patel; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.